Outcome
Neither tumour site nor histology (p=0.28) was predictive of outcome.
Patients who received chemotherapy had significantly better outcomes
compared to those who did not, on both univariate (p<0.0007)
and multivariate (p<0.001) analysis, irrespective of whether a
carboplatin-based or cisplatin-based regimen was used.
In conclusion, only stage (p<0.001), administration of
chemotherapy (p<0.001) and an elevated serum level of AFP
> 33,000ng/ml (p=0.002) were independently predictive of
outcome. The result of the multivariate analysis is summarised in Fig.
S1.
The five year OS for the group was good at 80.4% with an EFS of 75.3%.